Company intelligence / Profile preview

Schroders

London, United Kingdom

Ownership: Private
Employees: ~5500
Development stage: Other

Overview

Schroders is a global asset management firm. Through its private markets and innovation-focused funds (such as Schroders Capital and Schroders Capital Global Innovation Trust), it invests in biomedical and life sciences companies at various clinical stages but is not itself a biotech, pharma, or healthcare company. It does not have a clinical pipeline of its own.

Industry: Investors

Beyond the preview

Go deeper on Schroders.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schroders.

Explore the full profile